This grant seeks to understand the role of Group 2 innate lymphoid cells (ILC2s) in sustaining an altered epithelial interface that is crucial to the establishment of an aberrant remodeled niche that contributes to the persistence of allergic pathology. The proposal is underpinned by publications supported in the prior grant, demonstrating (1) a key role for tissue-elaborated epithelial cytokines in the activation of tissue type 2 immune cells, including ILC2s; and (2) discovery of a feed-forward epithelial-ILC2 circuit in the intestines that drives goblet cell hyperplasia and tissue hyperplasia, providing the impetus for uncovering similar circuitry in the respiratory system. As shown by colleagues in Project 3, severe, drug-recalcitrant, asthma is populated disproportionately with patients with relatively ?fixed? airway abnormalities associated with persistent mucus plugs; a significant proportion of individuals also have recurrent nasal polyposis. Together with our discoveries in model animal systems, our over-arching hypothesis is that dysregulated epithelial-ILC2 circuits in the respiratory tract, including nasopharynx (NP), trachea and airways, underlie the presence of persistent niches where allergic pathology is sustained. Using novel genetic tools in mice that permit exquisite dissection of such circuits, we propose 3 Specific Aims that align within the overall goals of the PPG. First, we will define the ILC2 landscape in mouse skin, NP, trachea and lung, where we have uncovered unsuspected diversity that has already been extended to human studies by others in the PPG. Second, we will define the tuft cell landscape in NP and trachea, since the critical role for this enigmatic epithelial cell was uncovered in our intestinal studies. We have demonstrated tuft cell hyperplasia in human allergic polyps. Third, we will use a mouse model of skin inflammation followed by lung allergen challenge to analyze the development of the epithelial-ILC2 circuit from skin to NP to lung, and the role of these respective cells. These findings will be applied to human tissues collected in Core B of this PPG and analyzed in Core C of this PPG to generate discovery in patients with severe asthma. Together, this PPG will uncover dysfunctional cellular networks and niches that sustain allergic immunopathology in the lung.

Public Health Relevance

Severe asthma is frequently marked by focal areas of intense allergic pathology, as characterized by mucus plugs and nasal polyps. This project pursues mouse models to gain basic understanding of the underlying pathways, and works with the other Projects and Cores to extend these discoveries to human patients. Ultimately, this may lead to strategies to therapeutically disrupt such areas and overcome disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL107202-07
Application #
10006351
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Noel, Patricia
Project Start
2012-08-15
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Peters, Michael C; Ringel, Lando; Dyjack, Nathan et al. (2018) A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma. Am J Respir Crit Care Med :
Wong-McGrath, Kelly; Denlinger, Loren C; Bleecker, Eugene R et al. (2018) Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control. Chest 153:378-386
Van Dyken, Steven J; Locksley, Richard M (2018) Chitins and chitinase activity in airway diseases. J Allergy Clin Immunol 142:364-369
Dunican, Eleanor M; Elicker, Brett M; Gierada, David S et al. (2018) Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest 128:997-1009
Fassett, Marlys S; Pua, Heather H; Simpson, Laura J et al. (2018) Identification of Functionally Relevant microRNAs in the Regulation of Allergic Inflammation. Methods Mol Biol 1799:341-351
Schneider, Christoph; O'Leary, Claire E; von Moltke, Jakob et al. (2018) A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 174:271-284.e14
Sui, Pengfei; Wiesner, Darin L; Xu, Jinhao et al. (2018) Pulmonary neuroendocrine cells amplify allergic asthma responses. Science 360:
Nusse, Ysbrand M; Savage, Adam K; Marangoni, Pauline et al. (2018) Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559:109-113
Ricardo-Gonzalez, Roberto R; Van Dyken, Steven J; Schneider, Christoph et al. (2018) Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol 19:1093-1099
Pavord, Ian D; Beasley, Richard; Agusti, Alvar et al. (2018) After asthma: redefining airways diseases. Lancet 391:350-400

Showing the most recent 10 out of 91 publications